Skip to main content

Peer Review reports

From: Urodynamic effectiveness of a beta-3 adrenoreceptor agonist (vibegron) for a pediatric patient with anticholinergic-resistant neurogenic detrusor overactivity: a case report

Original Submission
29 Jul 2020 Submitted Original manuscript
3 Aug 2020 Reviewed Reviewer Report - Apul Goel
10 Aug 2020 Reviewed Reviewer Report - Jk Mahajan
28 Aug 2020 Author responded Author comments - Taiki Kato
Resubmission - Version 2
28 Aug 2020 Submitted Manuscript version 2
4 Sep 2020 Reviewed Reviewer Report - Jk Mahajan
6 Sep 2020 Reviewed Reviewer Report - Apul Goel
30 Sep 2020 Author responded Author comments - Taiki Kato
Resubmission - Version 3
30 Sep 2020 Submitted Manuscript version 3
5 Oct 2020 Author responded Author comments - Taiki Kato
Resubmission - Version 4
5 Oct 2020 Submitted Manuscript version 4
8 Oct 2020 Author responded Author comments - Taiki Kato
Resubmission - Version 5
8 Oct 2020 Submitted Manuscript version 5
15 Oct 2020 Author responded Author comments - Taiki Kato
Resubmission - Version 6
15 Oct 2020 Submitted Manuscript version 6
23 Oct 2020 Author responded Author comments - Taiki Kato
Resubmission - Version 7
23 Oct 2020 Submitted Manuscript version 7
Publishing
27 Oct 2020 Editorially accepted
18 Feb 2021 Article published 10.1186/s13256-020-02564-w

You can find further information about peer review here.

Back to article page